🔗 Share this article

A shadow market for unlicensed weight-loss drugs is being driven by TikTok fitness influencers and vendors on messaging platforms, based on recent findings.

Experimental Drug Gaining Traction Via Social Media

The experimental drug, which remains in research studies, is being promoted by social media influencers for its supposed fat-burning effects. Followers are encouraged to message these profiles directly for source information, while also obtaining discount codes.

Active Trade on Messaging Platforms

Additionally, a flourishing market exists on Telegram, where groups with numerous of members share comparison images, administration instructions and assertions of rapid UK delivery. Vendors promote the drug there before directing buyers to other platforms for transactions.

Learning About The Experimental Drug

Retatrutide is an investigational injectable created by US drugmaker Eli Lilly. The drug affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could assist individuals lose up to a quarter of their body weight. Referred to as the “triple G”, the drug is being promoted online as the successor to Ozempic.

Healthcare Experts Express Concerns

However, doctors and chemists have cautions that the distribution of what remains an unapproved drug in the UK is a cause for concern and could result in individuals administering substances of unknown origin.

Several experts stated the popularity for retatrutide could be connected to the increasing price of approved weight loss treatments such as Mounjaro.

Legal Status and Implementation

Selling the unapproved drug on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unapproved medication that cannot be promoted or supplied for human use under the Human Medicines Regulations 2012.

Some influencers try to sidestep the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and distribution can still breach medicines, advertising, and customer regulations, potentially leading to fines, legal action or imprisonment.

Service Response and Content Elimination

According to TikTok, the platform has removed violative material and banned associated hashtags and query recommendations. The company stated it was dedicated to keeping the service safe and allocating resources in strengthening enforcement strategies.

Online Trading Operations

Research also found communities with up to 9,000 participants marketing the experimental drug using the platform's integrated search feature, which functions like a online catalog. Typing “retatrutide” immediately displays groups with numerous of users, filled with photos of weight loss, glowing reviews and detailed guides for mixing or injecting at residence.

Within minutes of entering one community, a vendor shared contact information, where most transactions take place. The seller sent an instruction manual and promised shipping within two days. When questioned whether the substance was authentic, one vendor said: “You can’t be sure.” Another shared a photo of a alleged testing documentation. Not one inquired about body mass, health issues or previous experience.

Item Information and Pricing

Inside these communities, posts display dark colored parcels with Royal Mail labels, stating to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, prepared at home with sterile water, or ready-to-use pens typically priced at £160 for 20 milligrams. When questioned how long a pen should last, sellers give conflicting responses varying between a several days to “depends on your body”.

Platform Moderation and Safety Actions

A representative for the messaging service said it regularly monitored dangerous content on its platform including content that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Medical Professional Cautions

“Individuals are administering substances they cannot confirm. Although the science behind retatrutide is sound, these online products may not include what they claim,” stated a pharmacy expert, the head of pharmacy at Chemist4U.

A medical professional of an online medical service linked the increase in interest to recent cost increases for authorized slimming drugs such as Mounjaro. “With costs rising, patients are turning to online platforms. But fake treatments are extremely dangerous. You can’t be certain what’s inside or whether the conditions they were produced in was sterile,” she said.

Her staff has previously seen individuals injured by self-injection from unconfirmed sources. “We recognize the disappointment, but buying from messaging apps or communication platforms is gambling with your well-being,” stated the doctor. “These substances could be impure or improperly measured.”

Manufacturer Statement

A representative from the pharmaceutical company stated retatrutide was in phase 3 clinical trials and had not been reviewed or approved by any government authority anywhere in the world. “Consequently at this time no one can sell [it] for personal consumption,” they explained, noting that any product “falsely representing itself as a company investigational product not yet approved … may expose patients to possibly significant health risks”.